70710-2039 : Miglustat 100 mg Oral Capsule


NDC: 70710-2039
Labeler: Zydus Pharmaceuticals USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Miglustat
Dosage Form: Oral Capsule
Application #: ANDA219111
Rev. Date: 


NDC Package Codes:

  • 70710-2039-8: 6 BLISTER PACK IN 1 CARTON (70710‑2039‑8) / 15 CAPSULE IN 1 BLISTER PACK (70710‑2039‑4)

Active Ingredients:

  • Miglustat

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Enzyme Stabilizer [EPC]
  • Enzyme Stabilizers [MoA]
  • Glucosylceramide Synthase Inhibitor [EPC]
  • Glucosylceramide Synthase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 10148-201 Miglustat 100 mg Oral Capsule by Cotherix, Inc.
  • 42799-708 Miglustat 100 mg Oral Capsule by Edenbridge Pharmaceuticals LLC.
  • 43975-310 Miglustat 100 mg Oral Capsule by Amerigen Pharmaceuticals Inc.
  • 51991-959 Miglustat 100 mg Oral Capsule by Breckenridge Pharmaceutical, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70710-2039 QR Code

< Prev: 70710-2038Next: 70710-2051 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.